Aarti Shares
Aarti Group Stocks
Check out the complete list of shares/stocks of Aarti Group listed on NSE & BSE.
| Company Name | ₹ LTP (Change %) | Volume | Market Cap | 52 Week High | 52 Week Low |
|---|---|---|---|---|---|
|
AARTIIND
Aarti Industries Ltd |
468.00 (-0.1%) | 816.4k | 16969.42 | 523.10 | 338.05 |
|
AARTIDRUGS
Aarti Drugs Ltd |
362.35 (-1.5%) | 152.1k | 3307.17 | 564.05 | 318.95 |
|
AARTISURF
Aarti Surfactants Ltd |
410.00 (4.0%) | 13k | 343.81 | 653.10 | 316.00 |
|
AARTIPHARM
Aarti Pharmalabs Ltd |
719.25 (1.8%) | 97.5k | 6520.56 | 971.00 | 585.00 |
🧺 Invest in the entire group with one basket order
Aarti Group is a name investors often return to for clear reasons. It is tied to India’s growing chemical and pharmaceutical sectors. The group operates in speciality chemicals, pharmaceuticals, and related segments that serve industries like agriculture, polymers, and healthcare across domestic and international markets with consistent demand. This presence across segments provides both scale and diversification.
Investors look at Aarti stocks because they are tied to long-term demand, not short-lived trends. Global supply shifts and rising exports have also brought fresh attention to Indian chemical companies, and Aarti is often part of that conversation. Investors need to be cautious and look at the basics before investing. Raw material costs, global demand cycles, regulations, debt levels, and expansion plans can all impact overall performance over time.
Here’s a simple look at where Aarti Group stands and what to check before investing.
About Aarti Group of Companies
Aarti Group started as a small chemical business and grew into a well-known industrial name in India. The group is founded and led by the Gogri family, which still plays an active role in its growth and direction. Over time, the business expanded step by step into larger and more complex segments.
The group mainly works in speciality chemicals, pharmaceuticals, and related areas. These sectors connect to industries like agriculture, polymers, and healthcare, which keep demand fairly stable across cycles. Among the listed companies, Aarti Industries Ltd is the largest and most tracked. Aarti Pharmalabs Ltd focuses on pharma manufacturing. Aarti Drugs Ltd operates in active pharmaceutical ingredients. Each company has a different role within the group.
Business performance has been mixed in recent years. Revenue growth has stayed steady, but margins and return ratios have seen pressure. Expansion plans and global demand continue to influence results across key business segments over time. For investors, the group offers exposure to chemicals and pharma in one place. Still, numbers need regular tracking and close review. Growth is visible, but consistency in profitability remains a key point to watch carefully.
Frequently Asked Questions
The Aarti Group does not have a single listed share. Investment is made through its individual companies, such as Aarti Industries Ltd, Aarti Drugs Ltd, and Aarti Pharmalabs Ltd. Shares are bought through a Demat and trading account with a registered broker. Select one of the listed companies, check its current price, and place an order on the stock exchange.
Long-term selection usually focuses on companies with consistent revenue growth, strong order visibility, and stable margins. Aarti Industries Ltd is tracked closely, with revenue growth of around 14% and promoter holding 42.09%, reflecting scale and ownership stability. Aarti Pharmalabs Ltd gains attention for its specialised operations and steady demand, though margin trends need tracking. Aarti Drugs Ltd shows more fluctuation, with variable margins and earnings, so performance needs closer review.
The Gogri family started the Aarti Group and continues to run it. Chandrakant V. Gogri founded the group. Key roles are handled by Rajendra V. Gogri and Rasesh C. Gogri across the main companies. Shares are not limited to one owner, as the listed companies also have holdings from institutions and public investors.
The largest stock in the Aarti Group is generally Aarti Industries Ltd, based on market value and overall scale. It has a wider business presence and a stronger revenue base compared to other group companies. The company is also more actively tracked in the market, which is reflected in its size and visibility among investors. Other companies in the group operate on a smaller scale.
Aarti Industries shows a fairly balanced ownership mix. Promoters hold 42.09%, which keeps control in place. Mutual funds and insurance together add a strong institutional base. Foreign investors also have a presence, showing global interest. Retail investors hold 25.8%, which keeps public participation active. This mix gives a clear view of who backs the company and how ownership is spread today.
The main stocks in the Aarti Group include Aarti Industries Ltd, Aarti Pharmalabs Ltd, and Aarti Drugs Ltd. Aarti Industries leads in size and market presence. Aarti Pharmalabs focuses on contract manufacturing. Aarti Drugs operates in the pharmaceutical products. Each company plays a different role, which helps in understanding how the group functions as a whole.
Debt levels differ across companies in the Aarti Group. Higher debt levels are usually seen at Aarti Industries Ltd, mainly due to continuous spending on new facilities and project additions. Debt at Aarti Pharmalabs Ltd remains moderate and is largely tied to business expansion and day-to-day funding needs. Aarti Drugs Ltd generally operates with relatively lower debt compared to others in the group.
Investors can also watch peers like Pidilite Industries, Gujarat Fluorochemicals, Navin Fluorine International, Deepak Nitrite, and Atul Ltd. These names operate in similar chemical segments. Their results, pricing trends, and expansion plans often give early signals about demand cycles and sector direction. Tracking them helps give a clearer context around Aarti Group and its position in the market today, along with how it compares on growth, margins, and future outlook over time.
Profit across the Aarti Group is led by Aarti Industries Ltd, driven by its large operations and strong export business. Aarti Pharmalabs Ltd adds steady earnings through its manufacturing work. Aarti Drugs Ltd also contributes, although profits can vary depending on pricing and demand in the market.